FDA approved initiation of Humanigen’s phase III study of lenzilumab in COVID-19 patients
On Apr. 15, 2020, Humanigen announced that U.S. Food and Drug Administration (FDA) had given permission to commence…
Vanda Pharma initiatied of “CALYPSO” to study role of genetic variation in COVID-19 infections in collaboration with University of Washington Medicine
On Apr. 15, 2020, Vanda Pharmaceuticals announced initiation of the CALYPSO program to study the role that human…
Philips teamed with University of Kentucky’s UK HealthCare to power state’s only eICU Clinical Command Center
On Apr. 15, 2020, Royal Philips and UK HealthCare, the clinical enterprise of the University of Kentucky, announced…
FDA authorized first-of-its-kind low-cost ventilator developed by University of Minnesota
On Apr. 15, 2020, the U.S. Food and Drug Administration (FDA) authorized the production and use of a…
Orthoï¾’s total antibody test for COVID-19 received Emergency Use Authorization from FDA
On Apr. 15, 2020, the FDA announced it granted Emergency Use Authorization to Ortho Clinical Diagnosticsï¾’ total antibody…
Vanda Pharma and Northwell Health conduct ODYSSEY trial in patients with severe COVID-19 pneumonia
On Apr. 15, 2020, Vanda Pharma and Northwell Health’s research arm, The Feinstein Institutes for Medical Research, announced…
Chembio Diagnostics received Emergency Use Authorization for DPP COVID-19 s for IgG and IgM antibodies
On Apr. 15, 2020, Chembio Diagnostics announced receipt of FDA Emergency Use Authorization (EUA) for its DPP COVID-19…
Philips detailed plans to increase its hospital ventilator production to 4,000 units/week by Q3 2020
On Apr. 14, 2020, Royal Philips announced that it planed to double the production of its hospital ventilators…
AstraZeneca initiated CALAVI clinical trial with Calquence against COVID-19
On Apr. 14, 2020, AstraZeneca initiated a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib)…
Sinovac announced approval of human clinical trial for a vaccine candidate against COVID-19
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
Philips detailed plans to increase hospital ventilator production to 4,000 units/week by Q3 2020
On Apr. 14, 2020, Royal Philips updated its plans to double the production of its hospital ventilators by…
Philips joined forces with Flex and Jabil to speed the production of hospital ventilators
On Apr. 14, 2020, Philips announced that it had joined forces with manufacturing partners Flex and Jabil to…
New Philips Respironics E30 ventilator introduced to help free up ICU units in wake of COVID-19
On Apr. 14, 2020, Philips announced its initiative to quickly scale production of its new Philips Respironics E30…
NantKwest and ImmunityBio announced therapeutics and vaccines for combatting COVID-19
On Apr. 14, 2020, NantKwest and ImmunityBio announced discussions with the FDA for vaccines and therapeutics to combat…
The Jackson Laboratory to provide expanded Coronavirus testing for Maine hospitals
On Apr. 14, 2020, the Jackson Laboratory (JAX) in collaboration with several Maine regional hospitals, announced that it…
CHF Solutions announced COVID-19 patients teated with Aquadex Therapy for fluid management when access to dialysis machines limited or not available
On Apr. 14, 2020, CHF Solutions announced that physicians on the frontlines of treating patients with COVID-19 have…
Meridian Bioscience offered SARS-CoV-2 antigens for COVID-19 antibody tests
On Apr. 14, 2020, Meridian Bioscience announced it had launched a series of recombinant antigens for high sensitivity…
Alberta Hope COVID-19 study tested early treatment option
On Apr. 13, 2020, a province wide trial was announced that will investigate the effectiveness of hydroxychloroquine (HCQ)…
FDA approved first therapy for children with debilitating and disfiguring rare disease
On Apr. 13, 2020 the FDA announced that given the increased demand for chloroquine phosphate and hydroxychloroquine sulfate,…
Large-scale analysis links glucose metabolism proteins in the brain to Alzheimerï¾’s disease biology
On Apr. 13, 2020, in the largest study to date of proteins related to Alzheimerï¾’s disease, a team…
Pluristem treated first COVID-19 patient in US under FDA single patient expanded access program
On Apr. 13, 2020, Pluristem Therapeutics announced it has treated its first patient suffering from COVID-19 complications in…
Bausch Health initiated VIRAZOLEï¾® (Ribavirin for inhalation solution, USP) clinical study in patients with COVID-19
On Apr. 13, 2020, Bausch Health announced it has initiated a clinical trial program in Canada evaluating an…
Emory University developed diagnostic antibody blood test to determine antibody-responses to COVID-19
On Apr. 13, 2020, Emory University developed a sensitive and specific diagnostic antibody, also known as serological tests,…
FDA authorized Athersys to initiate pvotal clinical trial evaluating MultiStemï¾® cell therapy in patients with COVID-19 induced ARDS
On Apr. 13, 2020, Athersys announced the FDA has authorized the Company to initiate a Phase 2/3 pivotal…
Aegis Sciences launched test for Coronavirus disease 2019 (COVID-19)
On Apr. 13, 2020, Aegis Sciences announced serving as a regional reference laboratory for COVID-19 testing being directed…
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
FDA approved first therapy for children with debilitating and disfiguring rare disease
On Apr. 10, 2020, the FDA approved AstraZeneca ‘s Koselugo (selumetinib) for treatment of pediatric patients, 2 years…
STERIS announced decontamination solution for rrespiratory masks
On Apr. 10, 2020, STERIS announced that the FDA issued an Emergency Use Authorization (EUA) for respirator decontamination….
Potential treatment for COVID-19 identified by BenevolentAI using artificial intelligence enters randomised clinical trial
On Apr. 10, 2020, BenevolentAI announced that baricitinib, which it had identified as a potential treatment for COVID-19,…
Terumo BCT and Marker Therapeutics received FDA Emergency Use Authorization to treat acute respiratory failure in COVID-19 patients
On Apr. 10, 2020, Terumo BCT and Marker Therapeutics announced the FDA issued an Emergency Use Authorization (EUA)…